文献速递眼底病与葡萄膜炎

2型糖尿病视网膜微血管与神经元改变:START2筛查项目解读

Retinal Microvascular and Neuronal Alterations in Type 2 Diabetes: Insights From a Population-Based Screening Program (START2).
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该回顾性横断面研究纳入998名2型糖尿病患者的1978只眼,采用超广角眼底照相、OCT和OCTA评估视网膜微血管与神经元改变。结果显示,同时存在中心和外周病变的眼微血管密度显著降低,年龄和血糖控制是早期微血管改变的关键决定因素,年龄和BMI与GCL-IPL厚度相关。

要点

  • 同时存在中心和外周视网膜病变的眼,其SCP和DCP血管密度显著低于无病变眼及仅外周病变眼。
  • GCL-IPL厚度与年龄较大和BMI较高相关,与病变分组无显著差异。
  • 年龄较大和糖化血红蛋白较高与SCP血管密度降低相关。

核心结论

  • 中心合并外周视网膜病变与更严重的微血管损伤相关。
  • 年龄和血糖控制是2型糖尿病早期视网膜微血管改变的关键决定因素。
  • 年龄和BMI与GCL-IPL厚度相关。

研究设计与样本

  • 回顾性横断面研究,纳入糖尿病视网膜病变筛查项目中的998名参与者共1978只眼。
  • 采用超广角眼底照相、OCT和OCTA(CIRRUS 5000 HD-OCT with AngioPlex)进行评估。
  • OCT测量GCL-IPL厚度,OCTA评估SCP和DCP的骨架化血管密度(SVD)。
  • 视网膜病变分为不可见、中心、外周或两者兼有,采用混合效应模型比较病变组并评估关联因素。

主要发现

  • 1978只眼中1468只(74%)无可见病变,510只(26%)有病变(仅外周229只,仅中心132只,两者兼有149只)。
  • 两者兼有病变眼较无病变眼SVD显著降低(SCP P=0.019;DCP P=0.035),较仅外周病变眼也显著降低(SCP P=0.005;DCP P=0.019)。
  • GCL-IPL厚度在各病变组间无显著差异。
  • GCL-IPL厚度与年龄较大(P<0.001)和BMI较高(P=0.020)相关。
  • SCP的SVD降低与年龄较大(P<0.001)和糖化血红蛋白较高(P=0.004)相关。

关键数值与推荐

  • 病变分组:无可见病变(1468眼,74%)、仅外周病变(229眼)、仅中心病变(132眼)、中心合并外周病变(149眼)。
  • 两者兼有病变眼较无病变眼SVD降低:SCP P=0.019,DCP P=0.035。
  • 两者兼有病变眼较仅外周病变眼SVD降低:SCP P=0.005,DCP P=0.019。
  • GCL-IPL厚度与年龄较大(P<0.001)和BMI较高(P=0.020)相关。
  • SCP的SVD降低与年龄较大(P<0.001)和糖化血红蛋白较高(P=0.004)相关。

临床怎么用

  • 在2型糖尿病筛查中应关注中心合并外周视网膜病变,提示更严重微血管损伤。
  • 评估早期视网膜微血管改变时应考虑年龄和血糖控制状况。
  • GCL-IPL厚度解读需结合年龄和BMI。
  • 建议多学科协作以改善早期检测、风险分层及眼部和全身管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To explore early microvascular and neuronal retinal alterations in type 2 diabetes mellitus (T2DM) and their associations with lesion distribution, systemic factors, treatment exposure, and lifestyle variables in a real-world screening cohort. METHODS: In this retrospective cross-sectional study, 1978 eyes from 998 participants observed in a diabetic retinopathy screening program underwent ultra-widefield fundus photography, optical coherence tomography (OCT), and OCT-angiography (OCTA) (CIRRUS 5000 HD-OCT with AngioPlex). Ganglion cell layer and inner plexiform layer (GCL-IPL) thickness was measured by OCT, and OCTA assessed skeletonized vessel density (SVD) in the superficial capillary plexus (SCP) and deep capillary plexus (DCP). Retinal lesions were classified as not visible or as central or peripheral, or both. Mixed-effects models were used to compare lesion groups and assess associations with systemic and lifestyle factors. RESULTS: Of 1978 eyes, 1468 (74%) had no visible lesions, and 510 (26%) showed lesions (229 peripheral only, 132 central only, 149 both). Eyes with both lesions exhibited significantly reduced SVD compared with eyes without lesions (SCP, P = 0.019; DCP, P = 0.035) and with peripheral-only lesions (SCP, P = 0.005; DCP, P = 0.019). No significant differences were found for GCL-IPL. GCL-IPL thickness was associated with older age (P < 0.001) and higher body mass index (P = 0.020), and reduced SVD-SCP was associated with older age (P < 0.001) and higher glycated hemoglobin (P = 0.004). CONCLUSIONS: Combined central and peripheral lesions are associated with greater microvascular impairment. Age and glycemic control are key determinants of early retinal microvascular changes in T2DM, and age and body mass index relate to GCL-IPL thickness, highlighting the need for a multidisciplinary approach to improve early detection, risk stratification, and ocular and systemic management.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Almeida AC, Pais M, Pinto I, et al. Retinal Microvascular and Neuronal Alterations in Type 2 Diabetes: Insights From a Population-Based Screening Program (START2). Invest Ophthalmol Vis Sci. 2026. PMID: 42929690. doi:10.1167/iovs.67.12.61

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。